期刊文献+

缬沙坦对糖尿病大鼠肾脏肥大及P^(27)表达的影响 被引量:2

Effects of valsartan on renal hypertrophy and expression of P^(27) in the kidney of diabetic rats
原文传递
导出
摘要 目的 探讨血管紧张素受体I拮抗剂(ATIRa)对糖尿病肾脏肥大及细胞周期蛋白P27表达的影响。方法 大鼠腹腔注射链尿佐菌素(STZ)诱发糖尿病模型,每日灌胃给予ATIRa缬沙坦(8mg/kg),共2周。采用图像分析仪测量肾小球和肾小管直径并结合净重/体质量比评价肾脏肥大状态,流式细胞仪定量检测肾皮质P27表达。结果 糖尿病组较对照组肾小球、肾小管直径增大、肾重/体质量比增加产、P27蛋白表达增强;缬沙坦治疗组较糖尿病组肾脏肥大减轻、P27表达减弱。结论 缬沙坦可能通过影响细胞周期蛋白P27表达而抑制肾脏肥大,从而发挥肾脏保护作用。 Objective To investigate the effects of valsartan on renal hypertrophy and the expression of p27 in the kidney of diabetic rats. Methods Diabetes was induced in 18 SD rats by intraperitoneal injection of STZ(65 mg/kg). Valsartan(40 mg/kg) was delivered daily by gavage from the next day of the induction to diabetes for 2 weeks. TD 2000 image pattern analysis system was used to detect diameters of each glomerular and tubular cross section; kidney/body weight ratio was also used as an index to evaluate renal hypertrophy. The expression of P27 was detected by flow cytometry. Results Diameters of glomerular and tubular cross section, kidney/body weight ratio and the expression of p27 increased in the diabetic kidneys(P < 0.05 ). Above alterations were ameliorated by valsartan treatment (P < 0. 05). Conclusion The protective effect of valsartan on diabetic kidney may be partly through inhibiting renal hypertrophy by regulating the expression of cell cycle related protein P27.
出处 《中华物理医学与康复杂志》 CAS CSCD 北大核心 2001年第5期312-313,共2页 Chinese Journal of Physical Medicine and Rehabilitation
关键词 缬沙坦 糖尿病肾病 P^27蛋白 肾脏肥大 治疗 Varsartan Diabetic nephropathy P27
  • 相关文献

参考文献1

  • 1文辉,中华内科杂志,1999年,38卷,157页

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部